Reflections on 2021 from St Emlyn’s
We asked each of the St Emlyn’s team for their reflections on 2021. We hope you have enjoyed the blog and podcast his year. Thank you, as ever, for all […]
Reflections on 2021 from St Emlyn’s Read More »
Search Results for: dan horner
CODA: Is Emergency Medicine a failed paradigm? Revisited with St Emlyn’s
This week the CODA team have re-released the video and audio from a talk I did with Scott Weingart at SMACC in Dublin. We were tasked with answering the question
CODA: Is Emergency Medicine a failed paradigm? Revisited with St Emlyn’s Read More »
JC: Re-evaluating risk factors for Cauda Equina. St Emlyn’s
The diagnosis of cauda equina in the emergency department is complex and has the potential for significant patient harm if we get it wrong. Linda Dykes put together an excellent
JC: Re-evaluating risk factors for Cauda Equina. St Emlyn’s Read More »
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s
Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More »
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s
The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More »
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s
The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s Read More »
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s
In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More »
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s
Oxygen targets in critically ill/injured patients has been something we’ve talked about on the blog before. In general the evidence to date has suggested that the routine prescription of oxygen
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s Read More »
Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s
Hot on the heels of a terrific pun and blog post about the use of Tocilizumab, capturing all the intrigue, hope and caution with the potential use of this novel therapeutic
Tocilizumorelikeit? The latest data on Tocilizumab. St Emlyn’s Read More »
JC: Lopinavir/Ritonavir in the treatment of COVID-19
We have been following the RECOVERY trial closely over the last few months. It’s the largest RCT of therapeutics for COVID-19 in the world and it’s already shown that hydroxychloroquine
JC: Lopinavir/Ritonavir in the treatment of COVID-19 Read More »